Company Overview and News

 
Still Cautious About Norfolk Southern

37m seekingalpha
Interestingly, the shares are less expensive now on a price-to-free cash flow basis than they were before the latest rally.
UNP CSX NSC CNI KSU

 
Nexeo, Union Pacific rise; Oracle, FedEx stumble

4h nzherald.co.nz
Specialty chemicals maker Univar agreed to buy Nexeo in a deal the companies valued at $2 billion.
UNP

6
Union Pacific to Implement Precision Scheduled Railroading

9h zacks
Union Pacific Corporation (UNP - Free Report) has announced a new operating plan — Unified Plan 2020 — incorporating the Precision Scheduled Railroading principles. The plan is a notable move toward the company’s aim at ensuring a safe, reliable and efficient railroad operation. Benefits from the plan are anticipated to aid Union Pacific in achieving an operating ratio (operating expenses as a percentage of revenues) of 60% by 2020 and thus pave the way for an operating ratio of 55%.
TXN UNP SKYW MDPEB CSX MDP TRN

1
Union Pacific to borrow from competition in its rail reforms

2018-09-17 nzherald.co.nz - 1
OMAHA, Neb. (AP) — Union Pacific plans to borrow some ideas from other major freight railroads as it works to improve its operations.
UNP

4
UNP / Union Pacific Corp. 8-K (Current Report)

2018-09-17 sec.gov - 4
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION
UNP

15
Apple's Innovation - Cramer's Mad Money (9/13/18)

2018-09-14 seekingalpha - 1
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, September 13.
STZ.B PG UNP GOOGL AAPL STZ AVAV NSC KSU MO

8
Dividend ETFs: Stock Selection Strategies Can Hurt Performance

2018-09-13 seekingalpha
Exchange traded funds ("ETFs") that focus on companies that pay dividends, follow a wide variety of stock selection strategies. These range from simply selecting the highest yielding dividend paying stocks in the market to sophisticated proprietary strategies with multiple selection criteria. We analyze the investment results of the most popular U.S. listed ETFs to determine which strategies work.
VIG ABT MTSI UNP O OPRF ABT MCY HRL SDY VALU ABM TRI MSFT

 
The Latest: 10th anniversary of Los Angeles rail disaster

2018-09-12 nzherald.co.nz
LOS ANGELES (AP) — The Latest on 10th anniversary of Los Angeles rail disaster (all times local):
UNP

1
Transportation Stocks - Leading Indicators Point Towards More Gains

2018-09-11 seekingalpha
Moreover, transportation stocks are outperforming 'the market' which is likely going to continue on the mid-term.
UNP XPO NSC

 
This Railroad Has Increased Its Dividend By Almost A Third In The Last Year.

2018-09-11 seekingalpha
Volumes for premium and industrial goods showed solid volume growth while energy and agricultural shipments declined.
UNP VALU KSU

38
Tracking How Far They Fell: August Service Sector Edition

2018-09-10 seekingalpha
During March and April, I wrote a series of articles that examined how far several large-cap service sector stocks might fall during a bear market.
UNP VPU CCL FDX ADBE NSC BRK.A NKE SPGI GWW MGA JNJ MG AAPL CCL PAYX

78
Tech Is Defenseless - Cramer's Mad Money (9/6/18)

2018-09-07 seekingalpha - 1
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, September 6.
ABT HD PFPT STZ.B FB TTWO UNP CMCSA DXCM PANW STZ ISRG CGC CRM ATVI CYBR GOOGL WEED TSLA CLX FTNT

 
Winning Stocks Keep Winning

2018-09-06 seekingalpha
Winners keep winning in the stock market, and the majority of fund managers are getting everything wrong.
UNP NSC

 
UNP / Union Pacific Corp. 8-K (Current Report)

2018-09-06 sec.gov
8-K September 6th UNITED STATES SECURITIES AND EXCHANGE COMMISSION
UNP

1
Tracking David Winters' Wintergreen Advisers Portfolio - Q2 2018 Update

2018-09-01 seekingalpha
The largest three positions in the 13F portfolio are Consolidated-Tomoka Land, Altria Group, and Union Pacific Corporation.
ESLT BIR BIREF UNP SWGAF RAI BATS 4162 CFRHF HEIO SWGAY SWGNF CFRUY MO

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

18h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

18h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

20h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to UNP / Union Pacific Corp. on message board site Silicon Investor.

GPC.C - Gunpowder Capital Corporation GPC.C - Gunpowder Capital Corporation GPC.C - Gunpowder Capital Corporation Gunpoint Exploration Gunpoint Exploration Gunpoint Exploration
FunPhone.com planning to go public? FunPhone.com planning to go public? FunPhone.com planning to go public? SunPower Announces Initial Public Offering SPWR SunPower Announces Initial Public Offering SPWR SunPower Announces Initial Public Offering SPWR
SUNPHARM Pharmaceuticals (SUNP) SUNPHARM Pharmaceuticals (SUNP) SUNPHARM Pharmaceuticals (SUNP) UNPH _ Uniphase UNPH _ Uniphase UNPH _ Uniphase
Deflation: Highly Likely? UNPH ADRX BGEN SBTK TDFX Article Deflation: Highly Likely? UNPH ADRX BGEN SBTK TDFX Article Deflation: Highly Likely? UNPH ADRX BGEN SBTK TDFX Article Sunport Medical (smqcf) Sunport Medical (smqcf) Sunport Medical (smqcf)
CUSIP: 907818108